Cleared Traditional

K884584 - TONGUE SEIZING FORCEPS WITH & WITHOUT RUBBER PADS (FDA 510(k) Clearance)

Class I Anesthesiology device.

K884584 · Eastmed Enterprises, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1988
Decision
12d
Days
Class 1
Risk

K884584 is an FDA 510(k) clearance for the TONGUE SEIZING FORCEPS WITH & WITHOUT RUBBER PADS. Classified as Forceps, Tube Introduction (product code BWB), Class I - General Controls.

Submitted by Eastmed Enterprises, Inc. (Marlton, US). The FDA issued a Cleared decision on November 14, 1988 after a review of 12 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5780 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Eastmed Enterprises, Inc. devices

Submission Details

510(k) Number K884584 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 02, 1988
Decision Date November 14, 1988
Days to Decision 12 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
127d faster than avg
Panel avg: 139d · This submission: 12d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code BWB Forceps, Tube Introduction
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 868.5780
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.